Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

213 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Recruiting

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

NCT05954910

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, China
View all 29 locations
View Trial Details
Recruiting

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

NCT05952024

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site Stamford, Connecticut, United States
View all 57 locations
View Trial Details
Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 54 locations
View Trial Details
Recruiting

Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)

NCT06977711

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University Hospital System San Antonio, Texas, United States
  • University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center San Antonio, Texas, United States
View Trial Details
Recruiting

Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

NCT04844866

Conditions
Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • LKH - Medizinische Universitaet Graz Graz, Austria
  • Universitatsklinikum Innsbruck Universitatsklinik fur Innere Medizin V Innsbruck, Austria
  • Ordensklinikum Linz GmbH Elisabethinen Linz, Austria
  • Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH) Vienna, Austria
View all 51 locations
View Trial Details

Related conditions